Suárez-Mendoza Aldo, Petersen-Aranguren Fernando, Almeida-Velasco Alejandra, Robles-García Rebeca, Camacho Álvaro, Fresán-Orellana Ana
Department of Psychiatry, Neuroscience Institute for Research and Emotional Development, Mexico City. Mexico.
Department of Medical Clinics, University Center of Health Sciences, University of Guadalajara, Jalisco. Mexico.
Arch Cardiol Mex. 2019;89(3):221-226. doi: 10.24875/ACME.M19000060.
Depression and anxiety are frequent comorbid conditions in cardiovascular diseases (CVDs); they are related to poor prognosis and higher mortality risk. Health providers need a clinical tool to identify these psychiatric conditions. The 14-item hospital anxiety and depression scale (HADS) is a screening tool used in patients with different medical conditions.
The aim of this study was to evaluate the psychometric properties of the HADS Mexican Spanish version in a broad sample of Mexican patients with CVDs.
A total of 953 individuals between 18 and 75 years old with ischemic or hypertensive cardiomyopathy were screened with the HADS Mexican Spanish version. Construct validity, internal consistency, and congruence coefficients of the scale were obtained.
The results showed two clear factors which correspond to the original two designated domains of the HADS, anxiety, and depression, with adequate reliability values (alpha > 0.80) and high congruence coefficients (> 0.90) when compared to the sample of other validation studies of the HADS.
The present study adds evidence of the validity and reliability of the HADS to assess the presence of both depression and anxiety in Mexican patients with CVD. Its central contribution is that it demonstrates its capacity to differentiate the presence and severity of depression and anxiety in this population.
抑郁症和焦虑症是心血管疾病（CVD）中常见的共病情况；它们与预后不良和较高的死亡风险相关。医疗服务提供者需要一种临床工具来识别这些精神疾病。14项医院焦虑抑郁量表（HADS）是一种用于不同疾病患者的筛查工具。
本研究的目的是在墨西哥广泛的CVD患者样本中评估HADS墨西哥西班牙语版本的心理测量特性。
使用HADS墨西哥西班牙语版本对953名年龄在18至75岁之间的缺血性或高血压性心肌病患者进行筛查。获得了该量表的结构效度、内部一致性和一致性系数。
结果显示出两个明确的因素，分别对应于HADS最初指定的两个领域，即焦虑和抑郁，与HADS其他验证研究的样本相比，具有足够的可靠性值（α>0.80）和高一致性系数（>0.90）。
本研究为HADS评估墨西哥CVD患者抑郁和焦虑的有效性和可靠性提供了证据。其核心贡献在于证明了它在该人群中区分抑郁和焦虑的存在及严重程度的能力。
